Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsVistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage trial testing its ability to reduce symptoms in...
Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.
1.
June 20, 2023, Health Bulletin No. 12.
2.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
3.
Investigations may result in novel combination therapies for early-stage lung cancers.
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
1.
Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review
2.
Cancer Susceptibility Landscapes in Precision Oncology
3.
Integrated Techniques in Oncology in the Digital Era
4.
Cancer Rates on the Rise: What Can We Do to Stop It?
5.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Updates on the First Line Management of ALK+ NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge